Valeant Pharmaceuticals International (VRX) · page 33 of 39
The slide uses a DCF-style valuation bridge to demonstrate upside potential from the current share price of $111.50.
Activist deck · valuation_table · show_valuation_bridge · balanced density
Slide locked Sign in to view
Slide schematic 5/6
callout 1/1 list 2/2 metric 0/1 table 1/1 title 1/1
1 without position metric 1
metric · primary
Components 6
primary bullet bullet primary valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1